Silk Cotton Tree — Benefits Deep Dive

Bombax ceiba is not one herb with one evidence base — it is one tree supplying four traditionally distinct materials, each with its own use, its own chemistry, and its own separate research literature. The root (semal musli) is sold as a reproductive tonic. The stem bark carries the widest scientific literature, touching blood pressure, bone density and metabolic syndrome. The gum (mochras) is the classical astringent for diarrhea and bleeding, and is also the thinnest part by research volume. The flower is both a genuine food and the most actively studied part, with real 2022–2026 research on metabolism, gut motility and skin repair. This distinction governs everything below: a finding about one part is never evidence about another, and every citation on every linked page names the specific part it actually tested. All of it, across all four parts, remains preclinical — cell culture and animal studies, with no clinical trial in humans for any indication, on any part, at any dose.

Deep-Dive Articles

Root: The Reproductive-Tonic Claim

Semal musli, the dried root of a young sapling, as a classical vrishya / vajikarana drug. The one controlled rat study this claim rests on, reported with its full mixed result — behavioral parameters significant, testosterone not — plus the safed-musli adulteration problem and why "erectile dysfunction" is a medical signal worth a real evaluation.

Stem Bark: Cardiovascular, Bone and Metabolic Research

The tree's most chemically varied research: bark-specific hypotensive constituents, an anti-osteoporotic rat study run against a real raloxifene comparator, and an anti-obesity rat study against gemfibrozil. Also untangles shamimin (leaf, 1999, bioactive) from shamiminol (bark, 2011, structure only) — two compounds, two parts, one nearly-identical name.

Mochras Gum: Astringency and Bleeding

The classical Ayurvedic astringent drug for diarrhea, dysentery and heavy menstrual bleeding — and the thinnest part of this tree by research volume, with exactly one gum-specific pharmacology paper. Covers a genuine 2025 antiulcer finding, a part-ambiguous 2024 human endometrial-cell result, and a real contradiction from the flower's own research.

Flower: Metabolic, Gut and Skin Research

The most actively researched part — eleven papers spanning antidiabetic, gut-motility, gut-barrier, antimicrobial, cancer-cell and skin-repair findings, including a 2026 human-keratinocyte wound-healing study, the strongest single result on any part of this tree by evidence tier.

Back to Table of Contents

Table of Contents

  1. Deep-Dive Articles
  2. Why This Page Is Organized by Plant Part, Not by Health Claim
  3. Key Research Papers: Root
  4. Key Research Papers: Stem Bark
  5. Key Research Papers: Gum
  6. Key Research Papers: Flower
  7. External Authoritative Resources
  8. Connections

Why This Page Is Organized by Plant Part, Not by Health Claim

Most Benefits pages on this site organize around health claims — immune function, blood sugar, wound healing — because a single herb typically contributes one kind of material regardless of which part supplied it. Bombax ceiba is a genuine exception, and this page's structure follows the plant rather than a template.

Four parts, four separate traditions, four separate research bodies:

  1. Root (semal musli) — harvested from a young sapling, sold as a reproductive tonic. One controlled animal study.
  2. Stem bark — the mature trunk's bark, carrying the widest range of distinct pharmacological findings: blood pressure, bone, metabolic syndrome, antimicrobial screening.
  3. Gum (mochras) — resinous exudate from a bark wound, the classical astringent for diarrhea and bleeding. The thinnest research base of the four.
  4. Flower — both a real food and the most actively studied part, with recent work spanning metabolism, gut function and skin repair.

The clearest demonstration of why this separation matters is a genuine contradiction the research itself produced: gum carries a centuries-old astringent, anti-diarrheal (motility-slowing) tradition, while the flower's own 2023 and 2026 research shows the opposite — prokinetic, motility-promoting, gut-barrier-protective effects. Both can be true at once because they concern different parts with different chemistry. A sentence like "Bombax ceiba is good for the gut," stated without naming which part, is not simplified — it is meaningless, and potentially points a reader toward the wrong material for what they actually want.

A second demonstration is chemical rather than physiological: the leaf compound shamimin (1999, reported hypotensive and hypoglycemic activity in animals) and the bark compound shamiminol (2011, structure elucidation only, no bioactivity ever reported) differ by two letters in their name, were isolated by the same research group, and are entirely different molecules from entirely different parts. Citing one for the other's evidence would not be a simplification either — it would be wrong.

Back to Table of Contents

Key Research Papers: Root

  1. Bhargava C, Thakur M, Yadav SK (2012). Effect of Bombax ceiba L. on spermatogenesis, sexual behaviour and erectile function in male rats. Andrologia, 44(Suppl 1):474-8. — PubMed
  2. Alrabie A et al. (2023). Metabolomics platform determination of the metabolite profile of Bombax ceiba L. root, and antibacterial & antidiabetic evaluation. Natural Product Research, 37(13):2263-2268. — PubMed
  3. Mararajah S et al. (2024). Chlorophytum borivilianum (safed musli) root extract and testicular/sperm function — a different plant, cited for comparison. Journal of Ethnopharmacology. — PubMed
  4. Ghantous I et al. (2026). Comorbidities of diabetes, hypertension and cardiovascular disease in erectile dysfunction severity. Maedica. — PubMed
  5. Gillman N et al. (2026). Temporal trends in ED treatment in the PDE5-inhibitor era, Australia. ANZ Journal of Surgery. — PubMed
  6. All Bombax ceiba root literature (PubMed search)

Full detail, including exactly how the one controlled study's result should and should not be read: Root: The Reproductive-Tonic Claim.

Back to Table of Contents

Key Research Papers: Stem Bark

  1. Saleem R et al. (2003). Hypotensive activity and toxicology of constituents from Bombax ceiba stem bark. Biological & Pharmaceutical Bulletin, 26(1). — PubMed
  2. Faizi S et al. (2011). Shamiminol: a new aromatic glycoside from the stem bark of Bombax ceiba. Natural Product Communications, 6(12):1897-900. — PubMed
  3. Shah SS et al. (2018). Phytochemical screening and antimicrobial activities of red silk cotton tree. Pakistan Journal of Pharmaceutical Sciences, 31(3):947-952. — PubMed
  4. Chauhan S et al. (2018). In-vitro osteoblast proliferation and in-vivo anti-osteoporotic activity of Bombax ceiba. BMC Complementary and Alternative Medicine, 18(1):233. Raloxifene comparator. — PubMed
  5. Gupta P et al. (2013). FAS and PTP-1B signaling in ameliorative potential of Bombax ceiba against high-fat-diet obesity. BMC Complementary and Alternative Medicine, 13:281. Gemfibrozil comparator. — PubMed
  6. Dharavath N et al. (2025). Phytomediated silver nanoparticles from the stem bark of Bombax ceiba. Drug Research. — PubMed
  7. All Bombax ceiba stem bark literature (PubMed search)

Full detail, including the shamimin/shamiminol naming trap and how to read the raloxifene and gemfibrozil comparisons honestly: Stem Bark: Cardiovascular, Bone and Metabolic Research.

Back to Table of Contents

Key Research Papers: Gum

  1. Upadhyay SS et al. (2025). Antiulcer activity of Bombax ceiba L. gum in rats: omics and network pharmacology. ACS Omega, 10(48):59044-59055. The one gum-specific pharmacology paper. — PubMed
  2. P A et al. (2024). Shalmali (Bombax ceiba) extract on human endometrial stromal cells. Cureus, 16(5):e60699. Part not specified in the abstract. — PubMed
  3. Lahiri KR et al. (2022). RCT of probiotic plus oral rehydration therapy for acute childhood diarrhea, India — a real trial in this material's traditional-use context that did not include it. Tropical Diseases, Travel Medicine and Vaccines. — PubMed
  4. Masood R et al. (2025). Managing abnormal uterine bleeding in bleeding disorders (tranexamic acid context). Research and Practice in Thrombosis and Haemostasis. — PubMed
  5. All Bombax ceiba gum literature (PubMed search)

Full detail, including why the flower's own research directly contradicts the gum's traditional astringent claim: Mochras Gum: Astringency and Bleeding.

Back to Table of Contents

Key Research Papers: Flower

  1. Paradee N et al. (2026). Bombax ceiba flower extract, wound healing in human keratinocytes and fibroblasts. Pharmaceutical Biology, 64(1):599-614. — PubMed
  2. Yin K et al. (2022). Chemical composition and hypoglycemic mechanism of Bombax ceiba flower. Frontiers in Nutrition, 9:1018733. — PubMed
  3. Wang L et al. (2023). Bombax ceiba flower extract against loperamide-induced constipation in mice. Pharmaceutical Biology, 61(1):125-134. — PubMed
  4. Zhang Q et al. (2026). Bombax ceiba flower polysaccharide against DSS-induced colitis in mice. Chemistry & Biodiversity, 23(3):e03434. — PubMed
  5. Diab KA et al. (2022). Cytotoxic and genotoxic activities of Bombax ceiba flowers in Huh7 liver cancer cells. Asian Pacific Journal of Cancer Prevention, 23(4). — PubMed
  6. Chan KT et al. (2024). Ethnopharmacology of the five-flowers herbal tea tradition, Hong Kong and South China. Journal of Ethnobiology and Ethnomedicine. — PubMed
  7. All Bombax ceiba flower literature (PubMed search)

Full detail on all eleven flower papers, including why volume of research is not the same as strength of evidence: Flower: Metabolic, Gut and Skin Research.

Back to Table of Contents

External Authoritative Resources

Back to Table of Contents

Connections

Back to Table of Contents